ACTIVE

Advanced Practical Diagnostics

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

508,3 k €

+52.8% YoY

Gross margin

2,3 M €

+11.8% YoY

Equity

2,5 M €

+25.5% YoY

Workforce

12,3 ETP

-5.4% YoY

What does Advanced Practical Diagnostics do?

Advanced Practical Diagnostics is a Private limited company incorporated in 2008. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Turnhout. It employs on average 12,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0806.556.285

Incorporation

18/09/2008

Legal form

Private limited company

Registered office

Raadsherenstraat 3
2300 Turnhout · FlandreSee on map

Contributed capital

1 900 000,00 €

Latest accounts

31/12/2025

Average workforce

12,3 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 32500Manufacture of medical and dental instruments and supplies 32500Manufacture of medical and dental instruments and supplies+2

Joint committees (2)

207
20700

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	2,3 M €	+11.8%	2,0 M €	+8.7%	1,9 M €	-3.0%	1,9 M €	+20.4%	1,6 M €	+40.9%	1,1 M €	-23.4%	1,5 M €	+1.0%	1,5 M €	+5.9%	1,4 M €	+8.8%	1,3 M €	+41.7%	902,5 k €	+44.6%	624,2 k €	-48.2%	1,2 M €	+1517%	-85,0 k €	-121%	412,8 k €	-23.0%	536,5 k €	+868%	-69,9 k €
EBITDA	1,0 M €	+22.0%	843,8 k €	+12.7%	748,8 k €	-1.0%	756,4 k €	+13.9%	664,1 k €	+235%	198,3 k €	-56.4%	454,9 k €	+18.1%	385,1 k €	+14.7%	335,6 k €	+1.4%	330,9 k €	+1193%	25,6 k €	+108%	-303,4 k €	-254%	196,8 k €	+115%	-1,3 M €	-285%	-336,4 k €	-101%	-167,2 k €	+47.4%	-317,8 k €
Operating result	618,7 k €	+38.3%	447,2 k €	+98.7%	225,0 k €	-26.7%	307,2 k €	+13.1%	271,7 k €	+277%	-153,9 k €	-229%	119,5 k €	+28.8%	92,8 k €	+41.1%	65,7 k €	-12.6%	75,2 k €	+135%	-212,6 k €	+61.9%	-557,9 k €	-704%	92,4 k €	+107%	-1,4 M €	-225%	-429,8 k €	-71.9%	-250,0 k €	+29.6%	-355,0 k €
Net result	508,3 k €	+52.8%	332,6 k €	+124%	148,3 k €	-42.5%	257,7 k €	+13.7%	226,6 k €	+213%	-200,3 k €	-914%	24,6 k €	-50.4%	49,7 k €	+565%	7,5 k €	-81.3%	39,9 k €	+115%	-268,2 k €	+55.3%	-599,5 k €	-1522%	42,2 k €	+103%	-1,4 M €	-223%	-438,5 k €	-69.6%	-258,5 k €	+27.4%	-355,9 k €
Balance sheet
Equity	2,5 M €	+25.5%	2,0 M €	+20.0%	1,7 M €	+9.8%	1,5 M €	+20.5%	1,3 M €	+22.0%	1,0 M €	+351%	228,1 k €	+12.1%	203,4 k €	+32.3%	153,8 k €	+5.1%	146,3 k €	+37.5%	106,4 k €	+147%	-225,3 k €	-160%	374,2 k €	+116%	-2,4 M €	-148%	-952,9 k €	-85.2%	-514,4 k €	-101%	-255,9 k €
Total assets	4,5 M €	+7.0%	4,2 M €	+5.8%	4,0 M €	-1.5%	4,0 M €	+13.6%	3,6 M €	-0.2%	3,6 M €	-4.7%	3,7 M €	+5.6%	3,5 M €	-0.5%	3,6 M €	+29.4%	2,8 M €	+10.5%	2,5 M €	+11.6%	2,2 M €	+35.6%	1,6 M €	+238%	486,4 k €	-20.0%	608,3 k €	-19.0%	750,9 k €	+64.1%	457,6 k €
Cash	193,6 k €	+739%	23,1 k €	+723%	2,8 k €	+255%	788,5 €	-4.3%	824,1 €	+123%	369,6 €	-98.9%	34,6 k €	+23.7%	27,9 k €	-45.1%	50,9 k €	+213%	16,3 k €	-67.3%	49,9 k €	+2371%	2,0 k €	-96.9%	65,5 k €	+93.4%	33,9 k €	+74.1%	19,5 k €	-61.6%	50,7 k €	+78.4%	28,4 k €
Debts	2,0 M €	-9.7%	2,2 M €	-4.4%	2,3 M €	-8.3%	2,5 M €	+9.8%	2,3 M €	-9.3%	2,5 M €	-27.6%	3,5 M €	+5.1%	3,3 M €	-2.0%	3,4 M €	+30.8%	2,6 M €	+9.3%	2,4 M €	-2.8%	2,5 M €	+93.2%	1,3 M €	-55.3%	2,8 M €	+82.0%	1,6 M €	+23.4%	1,3 M €	+77.7%	712,1 k €
Other
Workforce	12,3 ETP	-5.4%	13,0 ETP	0.0%	13,0 ETP	-1.5%	13,2 ETP	+3.1%	12,8 ETP	-8.6%	14,0 ETP	-0.7%	14,1 ETP	+2.9%	13,7 ETP	+6.2%	12,9 ETP	+0.8%	12,8 ETP	+16.4%	11,0 ETP	+6.8%	10,3 ETP	-3.7%	10,7 ETP	-10.1%	11,9 ETP	+19.0%	10,0 ETP	-8.3%	10,9 ETP	+211%	3,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Pascale Verstappen

Director

Active

Ended mandates

Pascale Verstappen

Director · since 05 avril 2013

Ended

Pascale Verstappen

Manager · since 05 avril 2013

Ended

FISALIS

Director · since 11 mai 2009 · until 11 mai 2014 · 0458.592.541

Represented by Vera Van derzypen

Ended

Pascale Verstappen

Managing director · since 18 septembre 2008 · until 05 avril 2013

Ended

At this address

Other companies at this address

Company	CBE no.
Caelus Lifesciences Belgium● Active	1024.636.041
HOVE● Active	0458.713.691
Pave● Active	0768.708.469

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/07/2026	25/08/2025	31/07/2024	13/07/2023	28/07/2022	14/07/2021
General meeting	30/06/2026	19/08/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	17/07/2026	Dutch	PDF
Abridged model	31/12/2024	19/08/2025	25/08/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	31/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	13/07/2023	Dutch	PDF
Abridged modelCorrection	31/12/2021	30/06/2022	28/07/2022	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	18/07/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	14/07/2021	Dutch	PDF
Abridged model	31/12/2019	27/07/2020	29/07/2020	Dutch	PDF
Abridged model	31/12/2018	29/06/2019	16/07/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	23/07/2018	Dutch	PDF
Abridged model	31/12/2016	06/05/2017	30/05/2017	Dutch	PDF
Abridged model	31/12/2015	07/05/2016	07/06/2016	Dutch	PDF
Abridged model	31/12/2014	23/05/2015	23/06/2015	Dutch	PDF
Abridged model	31/12/2013	03/05/2014	26/06/2014	Dutch	PDF
Abridged model	31/12/2012	04/05/2013	30/05/2013	Dutch	PDF
Abridged model	31/12/2011	05/05/2012	20/06/2012	Dutch	PDF
Abridged model	31/12/2010	07/05/2011	27/05/2011	Dutch	PDF
Abridged model	31/12/2009	01/05/2010	03/06/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Pascale Verstappen

Director

Active

Ended mandates

Pascale Verstappen

Director · since 05 avril 2013

Ended

Pascale Verstappen

Manager · since 05 avril 2013

Ended

FISALIS

Director · since 11 mai 2009 · until 11 mai 2014 · 0458.592.541

Represented by Vera Van derzypen

Ended

Pascale Verstappen

Managing director · since 18 septembre 2008 · until 05 avril 2013

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/12/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Other31/10/2018
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares22/04/2015
KAPITAAL - AANDELEN
PDF
Registered office08/10/2014
MAATSCHAPPELIJKE ZETEL
PDF
Mandates24/04/2013
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates22/05/2009
ONTSLAGEN - BENOEMINGEN
PDF
Other02/10/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025508,3 k €↑
2024
Annual accounts 2024332,6 k €↑
2023
Annual accounts 2023148,3 k €↓
2022
Annual accounts 2022257,7 k €↑
2021
Annual accounts 2021226,6 k €↑
2020
Annual accounts 2020-200,3 k €↓
2019
Annual accounts 201924,6 k €↓
2018
Annual accounts 201849,7 k €↑
2017
Annual accounts 20177,5 k €↓
2016
Annual accounts 201639,9 k €↑
2015
Annual accounts 2015-268,2 k €↑
2014
Annual accounts 2014-599,5 k €↓
2013
Annual accounts 201342,2 k €↑
2012
Annual accounts 2012-1,4 M €↓
2011
Annual accounts 2011-438,5 k €↓
2010
Annual accounts 2010-258,5 k €↑
2009
Annual accounts 2009-355,9 k €
18/09/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Advanced Practical Diagnostics

Overview

What does Advanced Practical Diagnostics do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline